Header

UZH-Logo

Maintenance Infos

Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial


Riemann, B; Krämer, J A; Schmid, K W; Dralle, H; Dietlein, M; Schicha, H; Sauerland, C; Frankewitsch, T; Schober, O; Study group, M S D S (2010). Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial. Nuklearmedizin, 49(3):79-84.

Abstract

The MSDS patients with locally aggressive differentiated thyroid cancer showed an excellent overall survival during a median follow-up of 6.1 years. According to the current AJCC/UICC 2009 classification, pT3 patients with minimal extrathyroidal extension revealed a significantly better event-free survival than pT4a patients with extensive extrathyroidal growth.

Abstract

The MSDS patients with locally aggressive differentiated thyroid cancer showed an excellent overall survival during a median follow-up of 6.1 years. According to the current AJCC/UICC 2009 classification, pT3 patients with minimal extrathyroidal extension revealed a significantly better event-free survival than pT4a patients with extensive extrathyroidal growth.

Statistics

Citations

Dimensions.ai Metrics
30 citations in Web of Science®
32 citations in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Nuclear Medicine
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Radiology, Nuclear Medicine and Imaging
Language:English
Date:2010
Deposited On:31 Jan 2011 15:43
Last Modified:23 Jan 2022 18:16
Publisher:Schattauer
ISSN:0029-5566
OA Status:Closed
Publisher DOI:https://doi.org/10.3413/nukmed-0302
PubMed ID:20505894
Full text not available from this repository.